VADIS Trial: Phase II Trial of Nelipepimut-S Peptide Vaccine in Women With DCIS of the Breast

Trial Profile

VADIS Trial: Phase II Trial of Nelipepimut-S Peptide Vaccine in Women With DCIS of the Breast

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Nelipepimut-S (Primary) ; Sargramostim
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Acronyms VADIS
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 30 Nov 2016 According to a Galena Biopharma media release, trial design will be presented at the upcoming San Antonio Breast Cancer Symposium.
    • 30 Nov 2016 According to a Galena Biopharma media release, this trial is expected to initiate by the end of the year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top